As of 6th DSMB report Feb 26, 2018: "Resverlogix, the clinical steering committee, and all investigators remain blinded to the trial data."
Also, from Clayton and Resverlogix IR in an email to me on Feb 20, 2018: "As you know this trial remains blinded and therefore, we do not have any access to who is on placebo or who is on drug, so these numbers are derived from all patients."
BearDownAZ